Medicare will negotiate prices for Part B injectable drugs for the first time, aiming to lower costs for millions of patients ...

A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with this condition worldwide, daily treatment has meant taking levodopa and ...

The phase 2 trial of CT-388, a once-weekly subcutaneous injection acquired as part of its $2.7 billion takeover of Carmot ...

Midazolam—a sedative used in three botched executions this year—is included in two of four drug combinations that can now be used by Oklahoma executioners ...

New Medicare data shows which drugs cost the most, how many seniors take them, and why both volume and price matter for Part ...

The U.S. government plans to lower Medicare costs for Botox by targeting its medical uses, marking a major shift in drug ...

LONDON — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. In a statement ...

Researchers have found that a long-acting injection, given just twice a year alongside standard drugs. Blood pressure is one of the most common health problems worldwide, yet it remains difficult to ...

As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.

Here’s what the science says.

Tiny self-propelled nanorobots use body chemistry to navigate directly to tumors and deliver cancer drugs more effectively.

Both companies now aim to win in the oral weight loss drug market.